Advancing mRNA-based Therapeutics for In Vivo Cellular Reprogramming: An Academic Perspective

Time: 11:30 am
day: Day Two


  • Utilizing highly efficient CD4+ T-cell targeting and genetic recombination using engineered CD4+ cell homing mRNA LNPs
  • Demonstrating efficacy in reducing fibrosis and restoring cardiac function in mice
  • Discussing applications to produce CAR-T cells in vivo using modified mRNA to treat various diseases